Citadel Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,391,302
Closed -$8.13M 6979
2022
Q4
$8.13M Buy
1,391,302
+269,873
+24% +$1.58M ﹤0.01% 1435
2022
Q3
$7.51M Buy
1,121,429
+530,305
+90% +$3.55M ﹤0.01% 1495
2022
Q2
$2.49M Buy
591,124
+570,731
+2,799% +$2.4M ﹤0.01% 2533
2022
Q1
$69K Sell
20,393
-54,891
-73% -$186K ﹤0.01% 5804
2021
Q4
$237K Buy
+75,284
New +$237K ﹤0.01% 5334
2021
Q3
Sell
-10,777
Closed -$45K 7386
2021
Q2
$45K Sell
10,777
-7,613
-41% -$31.8K ﹤0.01% 6223
2021
Q1
$92K Buy
+18,390
New +$92K ﹤0.01% 5895
2020
Q4
Hold
0
5787
2020
Q3
Hold
0
5475
2020
Q2
Sell
-72,128
Closed -$637K 5493
2020
Q1
$637K Sell
72,128
-29,605
-29% -$261K ﹤0.01% 3220
2019
Q4
$939K Sell
101,733
-42,897
-30% -$396K ﹤0.01% 3045
2019
Q3
$850K Buy
144,630
+66,517
+85% +$391K ﹤0.01% 3060
2019
Q2
$937K Buy
78,113
+34,582
+79% +$415K ﹤0.01% 3031
2019
Q1
$525K Buy
43,531
+4,598
+12% +$55.5K ﹤0.01% 3343
2018
Q4
$489K Sell
38,933
-37,594
-49% -$472K ﹤0.01% 3288
2018
Q3
$1.14M Sell
76,527
-24,132
-24% -$358K ﹤0.01% 2611
2018
Q2
$1.69M Sell
100,659
-61,927
-38% -$1.04M ﹤0.01% 2271
2018
Q1
$3.72M Buy
162,586
+92,625
+132% +$2.12M ﹤0.01% 1491
2017
Q4
$1.81M Sell
69,961
-54,718
-44% -$1.42M ﹤0.01% 1975
2017
Q3
$1.84M Sell
124,679
-350,869
-74% -$5.18M ﹤0.01% 1875
2017
Q2
$6.63M Buy
+475,548
New +$6.63M 0.01% 1049
2016
Q2
Sell
-42,474
Closed -$580K 4052
2016
Q1
$580K Sell
42,474
-48,252
-53% -$659K ﹤0.01% 2123
2015
Q4
$1.72M Buy
90,726
+51,933
+134% +$985K ﹤0.01% 1650
2015
Q3
$728K Buy
+38,793
New +$728K ﹤0.01% 2351
2015
Q2
Sell
-19,333
Closed -$293K 4226
2015
Q1
$293K Sell
19,333
-40,084
-67% -$607K ﹤0.01% 2937
2014
Q4
$791K Buy
+59,417
New +$791K ﹤0.01% 2261